Stay ahead with actual insights from Spain. Here are the outcomes compiled by Porib.

 

🏛️ 36 HTA assessments were completed in Q2

✅ 7 new medicines reimbursed

🧬 7 orphan drugs reimbursed

🌟 7 new indications of previously reimbursed drugs

❌ 10 Not reimbursed

 

13 allegations after an initial decision of non-reimbursement

💰️ 4 Reimbursed after accepted allegations

⛔9 Not reimbursed after non-acceptance of allegations

 

📝 Register here to receive the latest and upcoming issues of the complete AccessBriefing with HTA insights from 14 countries, compiled by 9 partners of our network 👉 https://forms.office.com/e/Jt8bPmVkdJ